These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8706017

  • 1. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
    Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA, Lucarelli E, Bates SE, Thiele CJ.
    Cancer Res; 1996 Aug 15; 56(16):3737-42. PubMed ID: 8706017
    [Abstract] [Full Text] [Related]

  • 2. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J, Kim CJ, Kaplan DR, Thiele CJ.
    Cancer Res; 2002 Nov 15; 62(22):6756-63. PubMed ID: 12438277
    [Abstract] [Full Text] [Related]

  • 3. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ.
    Cancer Res; 1995 Apr 15; 55(8):1798-806. PubMed ID: 7712490
    [Abstract] [Full Text] [Related]

  • 4. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH, Li AM, Chen S, Tong HX, Zhang KR, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 15; 10(1):47-50. PubMed ID: 18289471
    [Abstract] [Full Text] [Related]

  • 5. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.
    Fryer RH, Kaplan DR, Kromer LF.
    Exp Neurol; 1997 Dec 15; 148(2):616-27. PubMed ID: 9417837
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
    Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, Iolascon A, Eggert A, Schramm A.
    Oncogene; 2009 May 14; 28(19):2015-23. PubMed ID: 19363525
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Study of brain-derived neurotrophic factor activating TrkB signaling cascades in the pathogenesis of multiple myeloma].
    Sun CY, Hu Y, Guo T, Huang J, Zhang L, Chu ZB.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr 14; 29(4):238-42. PubMed ID: 18843977
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Retinoic acid induced differentiation is mediated by trkB receptors.
    Lucarelli E, Kaplan D, Matsumoto K, Sickafuse S, Thiele CJ.
    Prog Clin Biol Res; 1994 Apr 14; 385():185-98. PubMed ID: 7972211
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.